Cellular and Molecular Neurobiology

, Volume 27, Issue 8, pp 1117–1126 | Cite as

Potential Interaction Between the GARS-AIRS-GART Gene and CP2/LBP-1c/LSF Transcription Factor in Down Syndrome-related Alzheimer Disease

  • Disha Banerjee
  • Krishnadas NandagopalEmail author
Original Paper


(1) GARS-AIRS-GART is an important candidate gene in studies of Down syndrome (DS)-related Alzheimer’s disease (AD), due to its chromosomal localization (21q22.1) in the Down syndrome critical region, involvement in de novo purine biosynthesis, and over-expression in DS brain. The aim of this study was to identify factor(s) likely to enhance transcription of GARS-AIRS-GART in DS-related AD. (2) Based on a bio-informatics approach, the PromoterInspector, Promoter Scan II, and EBI toolbox CpG plot software programs were used to identify GARS-AIRS-GART sequences important for gene transcription. Transcription factor binding motifs within these regions were mapped with the help of the MatInspector and TFSEARCH programs. Factors implicated in neurodevelopment or neurodegeneration were the focus of attention, and mining of human (T1Dbase) and murine (GNF) expression databases revealed information on the regional distribution of these factors and their relative abundance vis-a-vis GARS-AIRS-GART. (3) The Leader-binding protein 1-c (LBP-1c/CP2/LSF) emerged as a promising candidate from these studies, as MatInspector and TFSEARCH analyses revealed a total of four CP2 binding sites with potential for functional interaction(s) within the promoter and CpG islands of GARS-AIRS-GART. Furthermore, two of these sites harbor sequences for methylation-sensitive restriction enzymes, which suggest that methylation status may, in part, regulate CP2-mediated transcription of GARS-AIRS-GART. A search of T1Dbase and GNF expression databases reveals co-expression of CP2 and GARS-AIRS-GART in brain regions relevant to DS-related AD. (4) The virtual screen identified CP2/LBP-1c/LSF as a factor that likely mediates enhanced transcription of GARS-AIRS-GART in DS-related AD.


Down syndrome GARS-AIRS-GART CP2 Astrocytic hypertrophy Oxidative stress Alzheimer’s disease LBP-1c/CP2/LSF 



Disha Banerjee is the recipient of a Senior Research Fellowship from CSIR grant 27(0131)/04/EMR-II awarded to Krishnadas Nandagopal. We thank the anonymous referee for helpful comments on our manuscript.


  1. Aimi J, Qiu H, Williams J, Zalkin W, Dixon JE (1990) De novo purine biosynthesis: cloning of human and avian cDNAs encoding the tri-functional glycinamide ribonucleotide synthetase-aminoimidazole ribonucleotide synthetase-glycinamide ribonucleotide transformylase by functional complementation in E. coli. Nucl Acids Res 18:6665–6672PubMedCrossRefGoogle Scholar
  2. Akiyama, Y (1998) “TFSEARCH: Searching Transcription Factor Binding Sites”.
  3. Allore R, O’Hanlon D, Price R, Neilson K, Willfard HF, Cox DR, Marks A, Dunn RJ (1988) Gene encoding the β subunit of S100 protein is on chromosome 21: implications for Down syndrome. Science 239:1311–1313PubMedCrossRefGoogle Scholar
  4. Allore R, Friend WC, O’Hanlon D, Neilson KM, Buamal R, Dunn RJ, Marks A (1990) Cloning and expression of human S100β gene. J Biol Chem 265:15537–15543PubMedGoogle Scholar
  5. Appleton MD, Haab W, Burti U, Orsulak PJ (1969) Plasma urate levels in mongolism. Am J Ment Defic 74:196–199PubMedGoogle Scholar
  6. Brodsky G, Barnes T, Bleskan J, Becker L, Cox M, Patterson D (1997) The human GARS-AIRS-GART gene encodes two proteins which are differentially expressed during human brain development and temporally over-expressed in cerebellum of individuals with Down syndrome. Hum Mol Genet 6:2043–2050PubMedCrossRefGoogle Scholar
  7. Brooksbank BW, Balazs R (1984) Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down’s syndrome fetal brain. Brain Res 318:37–44PubMedGoogle Scholar
  8. Cunningham JM, Vanin EF, Tran N, Valentine M, Jane SM (1995) The human transcription factor CP2 (TFCP2), a component of the human gamma-globin stage selector protein, maps to chromosome region 12q13 and is within 250 kb of the NF-E2 gene. Genomics 30:398–399PubMedGoogle Scholar
  9. Degrell I, Niklasson F (1988) Purine metabolites in the CSF in presenile and senile dementia of Alzheimer type, and in multi infarct dementia. Arch Gerontol Geriatr 7:173–178PubMedCrossRefGoogle Scholar
  10. Dynlacht BD, Attardi LD, Admon A, Freeman M, Tjian R (1989) Functional analysis of NTF-1, a developmentally regulated Drosophila transcription factor that binds neuronal cis elements. Genes Dev 3:1677–1688PubMedCrossRefGoogle Scholar
  11. Epstein CJ (2001) Down syndrome (Trisomy21). In: Scriver CR, Beaudet AL, Valle D, Sly WS, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic and molecular basis of inherited disease, vol I. McGraw-Hill Medical Publishing Division, pp 1223–1256Google Scholar
  12. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349:704–706PubMedCrossRefGoogle Scholar
  13. Hard RG, Benkovic SJ, Van Keuren ML, Graw SL, Drabkin HA, Patterson D (1986) Assignment of a third purine biosynthetic gene (glycinamide ribonucleotide transformylase) to human chromosome 21. Am J Hum Genet 39:179–185Google Scholar
  14. Head E, Lott IT (2004) Down syndrome and beta-amyloid deposition. Curr Opin Neurol 17:95–100PubMedCrossRefGoogle Scholar
  15. Huminiecki L, Lloyd AT, Wolfe KH (2003) Congruence of tissue expression profiles from Gene Expression Atlas, SAGEmap and TissueInfo databases. BMC Genomics 4(1):31PubMedCrossRefGoogle Scholar
  16. Kim H-S, Kim E-M, Lee J-P, Park CH, Kim S, Seo J-H, Chang K-A, Yu E, Jeong S-J, Chong YH, Suh Y-H (2003) C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3β expression. FASEB J 17:1951–1953PubMedGoogle Scholar
  17. Lim LC, Swendeman SL, Shefferey M (1992) Molecular cloning of α-Globin transcription factor CP2. Mol Cell Biol 12:828–835PubMedGoogle Scholar
  18. Lim LC, Fang L, Swendeman SL, Shefferey M (1993) Characterization of the molecularly cloned murine alpha-globin transcription factor CP2. J Biol Chem 268:18008–18017PubMedGoogle Scholar
  19. Murata T, Nitta M, Yasuda K (1998) Transcription factor CP2 is essential for lens-specific expression of the chicken αA-crystallin gene. Genes Cells 3:443–457PubMedCrossRefGoogle Scholar
  20. Panza F, D'Introno A, Colaciccco AM, Capurso C, Basile AM, Torres F, Capurso A, Solfrizzi V (2004) LBP-1c/CP2/LSF gene polymorphism and risk of sporadic Alzheimer’s disease. J Neurol Neurosurg Psychiatry 75:166–168PubMedGoogle Scholar
  21. Patterson D, Graw S, Jones C (1981) Demonstration by somatic cell genetics, of coordination of genes for two enzymes of purine synthesis assigned to human chromosome 21. Proc Natl Acad Sci USA 78:405–409PubMedCrossRefGoogle Scholar
  22. Prestridge DS (1995) Predicting Pol II Promoter Sequences Using Transcription Factor Binding Sites. J Mol Biol 249:923–932PubMedCrossRefGoogle Scholar
  23. Puukka R, Puukka M, Perkkila L, Kouvalainen K (1986) Levels of some purine metabolizing enzymes in lymphocytes from patients with Down syndrome. Biochem Med Metab Biol 36:45–50PubMedCrossRefGoogle Scholar
  24. Quandt K, Frech K, Karas H, Wingender E, Werner T (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucl Acids Res 23:4878–4884PubMedCrossRefGoogle Scholar
  25. Rathbone MP, Middlemiss PJ, Gysbers JW, Andrew C, Herman MAR, Reed JK, Ciccarelli R, Di Iorio P, Caciagli F (1999) Trophic effects of purines in neurons and glial cells. Prog Neurobiol 59:663–690PubMedCrossRefGoogle Scholar
  26. Rice P, Longden I, Bleasby A (2000) EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 16:276–277PubMedCrossRefGoogle Scholar
  27. Scherf M, Klingenhoff A, Werner T (2000) Highly specific localization of promoter regions in large genomic sequences by PromoterInspector: A novel context analysis approach. J Mol Biol 297:599–606PubMedCrossRefGoogle Scholar
  28. Schupf N, Kapell D, Le JH, Ottman R, Mayeux R (1994) Increased risk of Alzheimer’s disease in mothers of adults with Down’s syndrome. Lancet 344:353–356PubMedCrossRefGoogle Scholar
  29. Schupf N, Kapell D, Nightingale B, Le JH, Mohlenhoff J, Bewley S, Ottman R, Mayeux R (2001) Specificity of the five-fold increase in AD in mothers of adults with Down syndrome. Neurology 57:979–984PubMedGoogle Scholar
  30. Shirra MK, Hansen U (1998) LSF and NTF-1 share a conserved DNA recognition motif yet require different oligomerization states to form a stable protein-DNA complex. J Biol Chem 273:19260–19268PubMedCrossRefGoogle Scholar
  31. Skrabanek L, Campagne F (2001) TissueInfo: high-throughput identification of tissue expression profiles and specificity. Nucl Acids Res 29(21):e102PubMedCrossRefGoogle Scholar
  32. St George-Hyslop PH, Tanzi RE, Polinsky RJ, Haines JL, Nee L, Watkins PC, Myers RH, Feldman RG, Pollen D, Drachman D (1987) The genetic defect causing familial Alzheimer’s disease maps on chromosome 21. Science 235:885–890PubMedCrossRefGoogle Scholar
  33. Su AI, Cooke MP, Ching KA, Hakok Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A, Patapoutian A, Hampton GM, Schultz PG, Hogenesch JB (2002) Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99:4465–4470PubMedCrossRefGoogle Scholar
  34. Swendeman SL, Spielholz C, Jenkins NA, Gilbert DJ, Copeland NG, Sheffery M (1994) Characterization of the genomic structure, chromosomal location, promoter, and developmental expression of the alpha-globin transcription factor CP2. J Biol Chem 269:11663–11671PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Manovikas Biomedical Research and Diagnostic CentreManovikas Kendra Rehabilitation and Research Institute for the HandicappedKolkataIndia

Personalised recommendations